Gemcitabine, Paclitaxel, Doxorubicin, and Pegfilgrastim in Treating Patients With Metastatic or Unresectable Bladder Cancer or Urinary Tract Cancer and Kidney Dysfunction
This study is ongoing, but not recruiting participants.
Study NCT00478361
Information provided by National Cancer Institute (NCI)
First Received: May 23, 2007
Last Updated: May 13, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
